Skip to main content
. 2017 Aug 10;4(1):40–47. doi: 10.1001/jamaoncol.2017.2303

Figure 3. Outcomes.

Figure 3.

A, Local progression from time of radiotherapy start, with death as a competing risk. B, Any progression from time of radiotherapy start, with death as a competing risk. C, Overall survival. HCC indicates hepatocellular carcinoma; RT, radiotherapy.